Trial of Intratumoral Injections of TTI-621 in Subjects With Relapsed and Refractory Solid Tumors and Mycosis Fungoides
Clinical trial NCT02890368 · TERMINATED
Trial details
- NCT number
- NCT02890368
- Sponsor
- Pfizer
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-01
- Primary completion
- 2020-03-31
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.